Inventor · disambiguated record
John Fitzmaurice Valliant
Also filed as: VALLIANT JOHN · VALLIANT JOHN F · VALLIANT JOHN FITZMAURICE
11 granted patents·13 pending applications·40 citations·filing 2002–2022
86Inventor score
Files withFUSION PHARMACEUTICALS INC7CENTRE FOR PROBE DEV AND COMMERCIALIZATION6UNIV MCMASTER6CARTER RANDALL LEE1GEN ELECTRIC1
Top patents by PatentIndex Score
24 records- 0192US10093741B1IGF-1R monoclonal antibodies and uses thereofFUSION PHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·20 cites·18 claims
- 0289US11191854B2Pharmacokinetic enhancements of bifunctional chelates and uses thereofCENTRE FOR PROBE DEV AND COMMERCIALIZATION·Filed 2018·Granted Dec 7, 2021·9 cites·16 claims
- 0384US11433148B2IGF-1R monoclonal antibodies and uses thereofCENTRE FOR PROBE DEV AND COMMERCIALIZATION·Filed 2018·Granted Sep 6, 2022·3 cites·40 claims
- 0478US11793895B2Residualizing linkers and uses thereofCENTRE FOR PROBE DEV AND COMMERCIALIZATION·Filed 2020·Granted Oct 24, 2023·1 cites·24 claims
- 0572US10758636B2Residualizing linkers and uses thereofCENTRE FOR PROBE DEV AND COMMERCIALIZATION·Filed 2014·Granted Sep 1, 2020·1 cites·1 claims
- 0668US11446401B2Actinium-225 and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·0 cites·1 claims
- 0768US2023270895A1Radioimmunoconjugates and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0866US2021290788A1Radioimmunoconjugates and dna damage and repair inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0965US2023052140A1Igf-1r monoclonal antibodies and uses thereofCENTRE FOR PROBE DEV AND COMMERCIALIZATION·Filed 2022·Application pending·0 cites
- 1063US9125955B299mTc imaging agents and methods of useGEN ELECTRIC·Filed 2013·Granted Sep 8, 2015·0 cites·6 claims
- 1163US2021290789A1Radioimmunoconjugates and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1262US2022054664A1Pharmacokinetic enhancements of bifunctional chelates and uses thereofCENTRE FOR PROBE DEV AND COMMERCIALIZATION·Filed 2021·Application pending·0 cites
- 1358US6890513B2Metal-carborane complexes for radioimaging and radiotherapy and methods for their preparationUNIV MCMASTER·Filed 2002·Granted May 10, 2005·4 cites·20 claims
- 1454US11491244B2Labeled fluorocarbon agents for positron emission tomography imagingUNIV MCMASTER·Filed 2018·Granted Nov 8, 2022·0 cites·14 claims
- 1551US2013195756A199mTc IMAGING AGENTS AND METHODS OF USEJOHNSON BRUCE FLETCHER·Filed 2012·Application pending·0 cites
- 1651US2024285818A1Radioimmunoconjugates and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1747US2021008229A1Targeted photoacoustic agents and uses thereofUNIV MCMASTER·Filed 2020·Application pending·0 cites
- 1846US2021395281A1Macrocyclic chelates and uses thereofFUSION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1945US2014065070A1Methods of preparing triazole-containing radioiodinated compoundsVALLIANT JOHN·Filed 2013·Application pending·0 cites
- 2045US2009005545A1Methods for purifying radiolabelled compoundsUNIV MCMASTER·Filed 2008·Application pending·0 cites
- 2142US7335347B2Methods for purifying radiolabelled compoundsUNIV MCMASTER·Filed 2003·Granted Feb 26, 2008·2 cites·18 claims
- 2240US2006062725A1Methods for preparing metal-carborane complexes for radioimaging and radiotherapyVALLIANT JOHN F·Filed 2005·Application pending·0 cites
- 2335US2016346409A1Targeted molecular imaging contrast agentsUNIV MCMASTER·Filed 2015·Application pending·0 cites
- 2434US8927732B2Biotin stannane for HPLC-free radioiodinationCARTER RANDALL LEE·Filed 2012·Granted Jan 6, 2015·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when John Fitzmaurice Valliant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →